A Case of Pneumocystis jirovecii Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and Infection

Pneumocystis jirovecii pneumonia is an opportunistic disease usually prevented by trimethoprim-sulfamethoxazole. A 49-year-old HLA-sensitized male with successful late conversion from tacrolimus-based to belatacept-based immunosuppression developed P. jirovecii pneumonia for which he presented sever...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Nephrol Dial
Main Authors: Perrier, Quentin, Portais, Antoine, Terrec, Florian, Cerba, Yann, Romanet, Thierry, Malvezzi, Paolo, Bedouch, Pierrick, Tetaz, Rachel, Rostaing, Lionel
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2021
Assuntos:
Single Case
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7923707/
https://ncbi.nlm.nih.gov/pubmed/33708795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000510842
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados